Wanbangde Pharmaceutical Holding Group Co., Ltd.

SZSE:002082.SZ

6.52 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income 26.32774.323161.16292.212208.832125.189100.4173.38568.433113.349117.25790.943162.461155.476123.07975.54465.02336.83620.56225.85420.235
Depreciation & Amortization 96.937107.03494.977107.11268.2669.3751.73755.73560.05561.16163.52862.79855.51756.00948.75835.81333.13828.92915.911.11210.463
Deferred Income Tax -21.604-31.189-15.263-23.4781.345-4.0420.229-0.046-0.702000000000000
Stock Based Compensation 000000000000000000000
Change In Working Capital -278.241-590.192-162.879-406.152-587.588-86.94-138.793180.508-116.092-37.53842.10424.215-233.568-55.781-108.304118.814-104.369-82.149-39.755-17.0341.214
Accounts Receivables -15.199-101.791178.826-626.938-501.343-171.773.55451.811-169.86850.389-81.103-31.052000000000
Inventory 20.814-18.70764.521-64.783-167.24-85.023-123.804131.06341.919-67.01837.597-2.33810.785-90.559-69.63427.5-58.267-40.947-44.259-17.152-2.673
Accounts Payables -262.253-438.505-390.963309.047-48.685173.825-88.772-2.3212.559000000000000
Other Working Capital -283.856-31.189-15.263-23.478129.68-1.917-14.9949.445-158.01129.4814.50726.553-244.35334.779-38.6791.314-46.102-41.2034.5040.1183.887
Other Non Cash Items 48.195169.188-71.172157.83461.80327.776-30.9591.0844.3673.33811.46424.77614.1536.5614.60122.89218.66119.88514.52112.7585.097
Operating Cash Flow -72.87-239.64822.085151.006-248.693135.396-17.605310.71316.763140.31234.353202.732-1.437162.26568.134253.06312.4533.50111.22732.69137.009
Investing Activities:
Investments In Property Plant And Equipment -128.724-167.231-277.06-559.243-405.979-199.638-20.883-9.029-30.469-44.91-12.451-40.917-134.293-44.024-60.017-146.924-109.681-93.467-87.856-98.304-37.917
Acquisitions Net 0.2016.3731,292.727-79.9-27.945-224.187-208.955.60513.319000000000.05500.0040
Purchases Of Investments -5-6.3730.267-44.8-22.230-235-260-220-35-1000000-9.6760-0.950
Sales Maturities Of Investments 7.4920.51.25.5130.50.5237.028264.404252.542000000005.5773.360.4060.231
Other Investing Activites -30.001-0.686-17.676-2.21461.143-3.54732.0040.123.141.3315.0774.2432.1521.3571.2333.04913.28115.318-11.4680.610.262
Investing Cash Flow -156.033-167.418999.457-680.643-394.511-426.873-195.8011.118.533-78.58-8.373-36.674-132.141-42.667-58.783-143.875-96.401-82.194-95.964-98.234-37.424
Financing Activities:
Debt Repayment -112.982-710.725-1,012.936-1,260.979-276.086-500-5-10-207-525-557.1-395.3-175.8-200-810.9-404.2-374.82-158.46-183.16-111.81
Common Stock Issued 09.02850.961000000000000000000
Common Stock Repurchased 0-9.028-50.961000000000000000000
Dividends Paid -73.403-43.907-122.855-92.733-50.214-24.727-59.5-23.809-12.329-1.972-29.952-69.742-49.402-35.63-27.558-35.509-26.526-17.417-19.508-8.537-5.221
Other Financing Activities 18.302691.566529.8471,871.3611,091.65492.5230-50.037121330.178583.5475.08212177.214846.837381.718605.036282.301273.36136.81
Financing Cash Flow 9.256-63.066-674.747439.61765.349417.797-59.5-28.809-22.292-87.972-224.774-43.34230.3780.57-50.3440.428-49.008212.799104.33381.66319.779
Other Information:
Effect Of Forex Changes On Cash -1.2482.024-5.4442.9390.562-0.062-0.1910.1670.2170.093-0.792-0.213-0.273-0.061-0.078-0.291-0.394-0.1330.037-0-0.039
Net Change In Cash -220.895-468.108341.351-87.088122.707126.258-273.097283.1713.221-26.1490.413122.503-103.473120.106-41.07109.325-133.349133.97319.63316.11919.326
Cash At End Of Period 218.151439.046907.154565.803522.048399.34273.083546.18263.01249.789275.938275.524153.021256.493136.388177.45868.133201.48367.5147.87631.757